Automated Immunoassay Analyzer Market Business Drivers, Competitive Strategies, and Research Report 2018 - 2023

The global automated immunoassay analyzer market is projected to exhibit a healthy CAGR during the forecast period. Rapid adoption of automated technology in diagnostic laboratories to spur demand for automated immunoassay analyzer. An automated immunoassay analyzer is a method or technique to spot the existence of a particular substance in the human body. It could be an antibody, antigen, hormone, pathogen, or an enzyme. Immunoassay technique is based on the principle of antibody and antigen specificity.

Leading players operating in the automated immunoassay analyzer market include Abbott Laboratories; Siemens Healthineers; bioMérieux SA; Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; Ortho-Clinical Diagnostics; Randox Laboratories; Radiometer APS; F. Hoffmann-La Roche Ltd.; SNIBE Diagnostics; DiaSorin S.p.A.; Thermo Fisher Scientific and Sysmex Corporation. The key players are focusing on inorganic growth to withstand themselves amidst fierce competition. As such, acquisitions, mergers, and joint ventures are the need of the hour in the automated immunoassay analyzer market.


Growing aged population has led to high diagnostic test volumes, growing inclination toward lab automation, increasing occurrences of infectious disease. In addition, technological advancements for the development of applicable lab equipment, and growing occurrences of infectious disease epidemics such as hepatitis infection, Zika disease, HIV, and others will propel automated immunoassay analyzers in the years to come. However, lack of skilled professionals, strict regulatory framework and high cost of the instruments may limit the automated immunoassay analyzer market growth in the forecast period.

ABBOTT PRISM is a fully automated, high-volume blood screening device intended to improve the safety of the blood supply. It is a test system for blood screening that reveals presence of viruses that might cause disease. This screening process includes multiple test instruments, numerous assays, and several manual steps. In addition, this instrument combines much of this testing into a single system, minimizes errors, and interference by automating the manual testing steps and procedures presently used to screen blood.

North America will continue to account for a large share in the market throughout the forecast period, owing to high adoption of technology in the U.S., and the strategic presence of key manufacturers.

Browse Related Category Reports @ https://industriesstudyreport.wordpress.com/

Key Questions Answered in This Report
• Analysis of the automated immunoassay analyzer market including revenues, future growth, market outlook
• Historical data and forecast
• Regional analysis including growth estimates
• Analyzes the end user markets including growth estimates.
• Profiles on automated immunoassay analyzer including products, sales/revenues, and market position
• Market structure, market drivers and restraints.

No comments:

Post a Comment

Clinical Research Organizations Procurement Supplier Intelligence Report, 2023 - 2030

Clinical Research Organizations Packaging Category - Procurement Intelligence   The Clinical Research Organization Category is expected to...